Qilu Hospital of Shandong University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1890-01-01

Employees: -

Market Cap: -

Website: https://www.qiluhospital.com

Clinical Trials

A Study of Fractional Carbon Dioxide Laser Treatment for Female Stress Urinary Incontinence

Not Applicable

Recruiting

Conditions: Stress Urinary Incontinence

Interventions: Procedure: Fractional carbon dioxide laser sham treatment
Procedure: Fractional carbon dioxide laser treatment

First Posted Date: 2022-11-29

Last Posted Date: 2023-03-06

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 120

Registration Number: NCT05629481

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

The Clinical Efficacy of Immunomodulators in RA Patients

Phase 4

Recruiting

Conditions: Arthritis, Rheumatoid

Interventions: Drug: Iguratimod
Drug: Adalimumab Injection
Drug: Methotrexate
Drug: Leflunomide
Drug: Hydroxychloroquine

First Posted Date: 2022-11-23

Last Posted Date: 2022-11-29

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 400

Registration Number: NCT05626348

Locations: 🇨🇳
Qilu Hospital, Jinan, Shandong, China

Lianhua Qingwen for the Rehabilitation of Patient With Coronavirus Infection

Phase 4

Recruiting

Conditions: Traditional Chinese Medicine
Coronavirus

Interventions: Drug: Lianhua Qingwen capsules

First Posted Date: 2022-11-22

Last Posted Date: 2022-11-22

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 4000

Registration Number: NCT05625035

Locations: 🇨🇳
International Convention and Exhibition Center Shelter Hospital, Urumqi, Xinjiang, China

Lianhua Qingke for the Rehabilitation of Patient With Omicron Infection

Phase 4

Recruiting

Conditions: Coronavirus
Traditional Chinese Medicine

Interventions: Drug: Lianhua Qingke tablets

First Posted Date: 2022-11-22

Last Posted Date: 2022-11-22

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 2000

Registration Number: NCT05625022

Locations: 🇨🇳
International Convention and Exhibition Center Shelter Hospital, Urumqi, Xinjiang, China

Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma

Completed

Conditions: Carcinoma

Interventions: Other: no intervention

First Posted Date: 2022-10-25

Last Posted Date: 2022-10-25

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 100

Registration Number: NCT05593744

Locations: 🇨🇳
Qilu Hospital, Shandong University, Jinan, Shandong, China

Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy

Phase 2

Recruiting

Conditions: Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Interventions: Drug: Serplulimab
Drug: Lenvatinib
Drug: Paclitaxel/Paclitaxel-albumin/Paclitaxel liposome

First Posted Date: 2022-10-19

Last Posted Date: 2023-10-19

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 59

Registration Number: NCT05585580

Locations: 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
🇨🇳
Qingdao Municipal Hospital（Group）, Qingdao, Shandong, China
🇨🇳
Yantai Yuhuangding Hospital, Yantai, Shandong, China

and more 4 locations

First-line Treatment With RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer

Phase 2

Not yet recruiting

Conditions: HER2-positive Gastric Cancer

Interventions: Drug: Disitamab vedotin
Drug: Tislelizumab
Drug: S1

First Posted Date: 2022-10-19

Last Posted Date: 2022-10-19

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 55

Registration Number: NCT05586061

Locations: 🇨🇳
Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
🇨🇳
Shandong Provincial Hospital Affiliated to Shandong First Medical Universiry, Jinan, Shandong, China
🇨🇳
The First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital), Jinan, Shandong, China

and more 4 locations

Clinical Efficacy of High-flow Nasal Cannula Oxygen Therapy in Patients With Obstructive Sleep Apnea

Not Applicable

Conditions: Obstructive Sleep Apnea

Interventions: Device: high-flow nasal cannula oxygen therapy,
Device: CPAP

First Posted Date: 2022-09-22

Last Posted Date: 2022-09-22

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 194

Registration Number: NCT05549245

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics

Completed

Conditions: Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease

First Posted Date: 2022-09-22

Last Posted Date: 2022-09-22

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 666

Registration Number: NCT05550805

Locations: 🇨🇳
Yuguo Chen, Jinan, Shandong, China

Long-term Effect of High Flow Nasal Canula Therapy on Obstructive Sleep Apnea

Not Applicable

Recruiting

Conditions: High Flow Nasal Canula
Obstructive Sleep Apnea
Continuous Positive Airway Pressure Ventilation

Interventions: Device: CPAP
Device: high-flow nasal canula oxygen therapy

First Posted Date: 2022-09-22

Last Posted Date: 2022-09-22

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 186

Registration Number: NCT05549310

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy